Michela Locci

4.8k total citations · 2 hit papers
21 papers, 1.8k citations indexed

About

Michela Locci is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Michela Locci has authored 21 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Michela Locci's work include T-cell and B-cell Immunology (12 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (8 papers). Michela Locci is often cited by papers focused on T-cell and B-cell Immunology (12 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (8 papers). Michela Locci collaborates with scholars based in United States, Italy and France. Michela Locci's co-authors include Shane Crotty, Emily Bettini, Mark A. Kroenke, Elias K. Haddad, Jennifer E. Wu, Pascal Poignard, Laura F. Su, Cecilia S. Lindestam Arlehamn, Mark M. Davis and Colin Havenar‐Daughton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Michela Locci

20 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses

2013 625 citations Michela Locci, Colin Havenar‐Daughton et al. Immunity profile →
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease

2023 46 citations Gunjan Arora, Thomas Hart et al. Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michela Locci United States	13	1.3k	256	253	251	220	21	1.8k
Salah-Eddine Bentebibel United States	11	2.2k 1.7×	214 0.8×	237 0.9×	395 1.6×	214 1.0×	19	2.8k
Kara Olson United States	10	1.7k 1.3×	237 0.9×	147 0.6×	401 1.6×	343 1.6×	18	2.1k
Victor Peña‐Cruz United States	14	1.1k 0.8×	329 1.3×	192 0.8×	288 1.1×	199 0.9×	19	1.5k
Christoph T. Berger Switzerland	23	803 0.6×	318 1.2×	241 1.0×	204 0.8×	344 1.6×	65	1.8k
Tyani D. Chan Australia	16	1.8k 1.4×	329 1.3×	123 0.5×	181 0.7×	83 0.4×	18	2.2k
Tess M. Brodie Switzerland	14	633 0.5×	247 1.0×	212 0.8×	242 1.0×	113 0.5×	30	1.2k
Lusijah Rott United States	16	1.7k 1.3×	252 1.0×	256 1.0×	503 2.0×	103 0.5×	19	2.4k
Lela Kardava United States	23	1.2k 0.9×	462 1.8×	232 0.9×	251 1.0×	325 1.5×	36	2.0k
Zoltán Bánki Austria	20	670 0.5×	171 0.7×	195 0.8×	127 0.5×	299 1.4×	48	1.0k
Hélène Le Buanec France	19	859 0.7×	322 1.3×	175 0.7×	147 0.6×	554 2.5×	45	1.3k

Countries citing papers authored by Michela Locci

Since Specialization

Citations

This map shows the geographic impact of Michela Locci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Locci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Locci more than expected).

Fields of papers citing papers by Michela Locci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michela Locci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Locci. The network helps show where Michela Locci may publish in the future.

Co-authorship network of co-authors of Michela Locci

This figure shows the co-authorship network connecting the top 25 collaborators of Michela Locci. A scholar is included among the top collaborators of Michela Locci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michela Locci. Michela Locci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Apostolidis, Sokratis A. & Michela Locci. (2024). SLE B cells take an extrafollicular detour after mRNA vaccination. Nature Immunology. 26(1). 4–6.

Castaño, Diana, Sidney Wang, Hannah Sharpe, et al.. (2024). IL-12 drives the differentiation of human T follicular regulatory cells. Science Immunology. 9(97). eadf2047–eadf2047. 9 indexed citations

Haque, Tamara T., Katherine A. Weissler, Zoe C. Schmiechen, et al.. (2024). TGFβ prevents IgE-mediated allergic disease by restraining T follicular helper 2 differentiation. Science Immunology. 9(91). eadg8691–eadg8691. 14 indexed citations

Arora, Gunjan, Thomas Hart, Emily Bettini, et al.. (2023). Development of an mRNA-lipid nanoparticle vaccine against Lyme disease. Molecular Therapy. 31(9). 2702–2714. 46 indexed citations breakdown →

Bettini, Emily, Katlyn Lederer, Hannah Sharpe, et al.. (2022). A combined fine needle aspiration and spectral flow cytometry approach to assess human germinal center responses to SARS-CoV-2 vaccination. STAR Protocols. 3(4). 101840–101840. 5 indexed citations

Palin, Amy, Galit Alter, Shane Crotty, et al.. (2022). The persistence of memory: defining, engineering, and measuring vaccine durability. Nature Immunology. 23(12). 1665–1668. 10 indexed citations

Bettini, Emily & Michela Locci. (2021). SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond. Vaccines. 9(2). 147–147. 185 indexed citations

Lu, Yisi, Ruoyi Jiang, Alec W. Freyn, et al.. (2020). CD4+ follicular regulatory T cells optimize the influenza virus–specific B cell response. The Journal of Experimental Medicine. 218(3). 37 indexed citations

Carnathan, Diane G., Kirti Kaushik, Ali H. Ellebedy, et al.. (2020). Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope Trimers. Frontiers in Immunology. 11. 1213–1213. 2 indexed citations

10.

Wing, James B., Yohko Kitagawa, Michela Locci, et al.. (2017). A distinct subpopulation of CD25⁻T-follicular regulatory cells localizes in the germinal centers. Proceedings of the National Academy of Sciences. 114(31). E6400–E6409. 151 indexed citations

11.

Locci, Michela, Jennifer E. Wu, Zbigniew Mikulski, et al.. (2016). Activin A programs the differentiation of human TFH cells. Nature Immunology. 17(8). 976–984. 121 indexed citations

12.

Hu, Joyce, et al.. (2016). CRISPR-Mediated Slamf1Δ/Δ Slamf5Δ/Δ Slamf6Δ/Δ Triple Gene Disruption Reveals NKT Cell Defects but Not T Follicular Helper Cell Defects. PLoS ONE. 11(5). e0156074–e0156074. 13 indexed citations

13.

Locci, Michela, Colin Havenar‐Daughton, Elise Landais, et al.. (2013). Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses. Immunity. 39(4). 758–769. 625 indexed citations breakdown →

14.

Kageyama, Robin, Jennifer L. Cannons, Fang Zhao, et al.. (2012). The Receptor Ly108 Functions as a SAP Adaptor-Dependent On-Off Switch for T Cell Help to B Cells and NKT Cell Development. Immunity. 36(6). 986–1002. 131 indexed citations

15.

Catucci, Marco, Marita Bosticardo, Maria Carmina Castiello, et al.. (2011). Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott–Aldrich syndrome. Gene Therapy. 19(12). 1150–1158. 8 indexed citations

16.

Bosticardo, Marita, Elena Draghici, Francesca Schena, et al.. (2011). Lentiviral-mediated gene therapy leads to improvement of B-cell functionality in a murine model of Wiskott-Aldrich syndrome. Journal of Allergy and Clinical Immunology. 127(6). 1376–1384.e5. 29 indexed citations

17.

Locci, Michela, Elena Draghici, Francesco Marangoni, et al.. (2009). The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. The Journal of Cell Biology. 185(1). i1–i1. 2 indexed citations

18.

Marangoni, Francesco, Marita Bosticardo, Sabine Charrier, et al.. (2009). Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott–Aldrich Syndrome in Preclinical Models. Molecular Therapy. 17(6). 1073–1082. 64 indexed citations

19.

Locci, Michela, Elena Draghici, Francesco Marangoni, et al.. (2009). The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. The Journal of Experimental Medicine. 206(4). 735–742. 42 indexed citations

20.

Bosticardo, Marita, Francesco Marangoni, Michela Locci, et al.. (2008). Long-term efficacy and safety of hematopoietic stem cell gene therapy mediated by lentiviral vectors in the murine model of Wiskott-Aldrich syndrome. Blood Cells Molecules and Diseases. 40(2). 256–257. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact